Patents by Inventor SAMUEL EARL BALDWIN

SAMUEL EARL BALDWIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8562575
    Abstract: The Holistic Breast Patch is the first known, non-pharmaceutical, effective device available which inhibits prolactin production safely and aids the relief of discomfort from breast engorgement pain by drying breast milk after pregnancy. The benefits of treatment of prolactin dependent diseases remain to be fully disclosed. It works transdermally and is comprised of a unique, approximately 1½ inch by ¾ inch natural and organic carbonyl disc housed within cotton gauze and nonstick adhesive Telfa®. It meets the Federal Drug Administration's definition of a non-significant risk device (21 CFR 812). Its use will aid in the treatment of prolactin dependent diseases and conditions and eliminate the serious risks of health complications and fatalities that have been documented by the use of prescription drugs, hormones and pharmaceuticals lacking FDA approval for this use by women. Wearing the Patch device is both easy and convenient.
    Type: Grant
    Filed: January 3, 2012
    Date of Patent: October 22, 2013
    Inventors: Samuel Earl Baldwin, Mary L. Benson
  • Publication number: 20130172832
    Abstract: The Holistic Breast Patch is the first known, non pharmaceutical, effective device available which inhibits prolactin production safely and aids the relief of discomfort from breast engorgement pain by drying breast milk after pregnancy. It will also aid in the treatment of prolactin dependent diseases and conditions that respond to prolactin inhibition. The availability of this device greatly eliminates the serious risks of health complications and fatalities that have been documented by the use of prescription drugs, hormones and pharmaceuticals lacking FDA approval for this use. The Holistic Breast Patch works transdermally and is comprised of a unique, natural and organic carbonyl disc housed within cotton gauze and nonstick adhesive Telfa forming an approximately 1½ inch by ¾ inch adhesive] patch. The Federal Drug Administration has determined it to be a non-significant risk device (21 CFR 812).
    Type: Application
    Filed: January 3, 2012
    Publication date: July 4, 2013
    Inventors: SAMUEL EARL BALDWIN, Mary L. Benson